RVMD Revolution Medicines, Inc.
RVMD Revolution Medicines, Inc.
Healthcare · Biotechnology
Market read
Scan convergence 1 scan as of 2026-10-23 1 neutral converging
POC $99.02 · VWAP $134.18 · +39.4% vs 12m avg buyer
Insiders selling 0 buy / 4 sell · Form 4, 90d $60M sold last open-market sell Kelsey Stephen Michael
Cluster CFO, COO + 6 others sold $11.3M, Sep 18–Oct 1
Coverage
1 watchlist
RVMD Price Structure
Loading timeframes…
Peers
Every watchlist RVMD belongs to, members best 30-day change first — RVMD highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@ibb
Reported the quarter ending 2026-06-30: diluted EPS -$3.06, net income -$644M (SEC filing). Across the print the stock moved +2.2% (close before → first close after).
full note →Against street estimates
How RVMD's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
RVMD research tape
62 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.